Stephan Hailfinger Selected Research

Stephan Hailfinger Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 10/2005
7	Lymphoma (Lymphomas) 01/2024 - 09/2010
7	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 10/2015
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 11/2009
3	Inflammation (Inflammations) 01/2020 - 10/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 04/2016 - 01/2013
2	Skin Diseases (Skin Disease) 10/2018 - 04/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2024
1	Multiple Myeloma 01/2024
1	Bites and Stings (Sting) 01/2024
1	Leukemia 01/2024
1	Fibrolamellar hepatocellular carcinoma 10/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 12/2021
1	Necrosis 01/2021
1	Rupture 01/2021
1	Confusion (Bewilderment) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Melanoma (Melanoma, Malignant) 05/2017
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2016
1	Carcinogenesis 11/2009
1	Hepatocellular Carcinoma (Hepatoma) 04/2007

Drug/Important Bio-Agent (IBA)

6	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 11/2009
6	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 02/2022 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2007
4	Transcription Factors (Transcription Factor)IBA 11/2020 - 09/2010
3	CytokinesIBA 11/2020 - 06/2016
3	Interleukin-17 (Interleukin 17)IBA 11/2019 - 10/2015
2	Imiquimod (Aldara)FDA LinkGeneric 11/2019 - 10/2015
2	Antigen Receptors (Antigen Receptor)IBA 04/2016 - 09/2010
2	NF-kappa B (NF-kB)IBA 08/2011 - 09/2010
1	Chimeric Antigen ReceptorsIBA 04/2024
1	AntigensIBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Glutamine (L-Glutamine)FDA Link 12/2023
1	AZD8186IBA 01/2023
1	vistusertibIBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022
1	LigandsIBA 10/2022
1	Peptides (Polypeptides)IBA 10/2022
1	CathepsinsIBA 12/2021
1	Endosomal Sorting Complexes Required for TransportIBA 01/2021
1	IronIBA 01/2021
1	Cyclin-Dependent Kinase 4IBA 11/2020
1	MethyltransferasesIBA 11/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Calcineurin InhibitorsIBA 01/2020
1	CalcineurinIBA 01/2020
1	CaspasesIBA 01/2020
1	NitrogenIBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2018
1	Y-Box-Binding Protein 1IBA 01/2018
1	VemurafenibIBA 05/2017
1	trametinibIBA 05/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2017
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 05/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 04/2016
1	IonomycinIBA 04/2016
1	ZymosanIBA 04/2016
1	Small Interfering RNA (siRNA)IBA 10/2015
1	ElementsIBA 11/2009
1	EnzymesIBA 09/2007
1	Fluconazole (Zonal)FDA LinkGeneric 03/2006
1	beta CateninIBA 03/2006
1	Codon (Codons)IBA 10/2005

Therapy/Procedure

6	Therapeutics 01/2023 - 05/2017
2	Immunotherapy 01/2024 - 10/2022
1	Stem Cell Transplantation 01/2024
1	Cell Transplantation 01/2022
1	Drug Therapy (Chemotherapy) 05/2017
1	Intradermal Injections 10/2015
1	Immunomodulation 08/2011